A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS and Parkinson's.

Cayuga Health neurologists have decades of experience treating Parkinson’s disease, a movement disorder of the nervous system. Parkinson’s symptoms develop over many years. People can have difficulty ...

Two drugs long prescribed to treat Parkinson's disease have been linked to heart-valve problems. Two studies in this week's New England Journal of Medicine present strong evidence that the drugs cause ...

(WNDU) - Visual hallucinations affect up to 75% of Parkinson’s patients. These visual hallucinations cause them to see things that aren’t really there. Now, there is a medication that targets these ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.

People with certain forms of early-onset Parkinson's disease could potentially benefit from taking a medication used to treat certain forms of cancer, according to new research by University of ...

Parkinson’s disease is a progressive disorder of later life, defined clinically by motor features (asymmetric bradykinesia, rigidity, tremor, and imbalance) and pathologically by neuronal degeneration ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Subscribe to our ...